Gregory L McIntire

Title: Gregory L McIntire: Innovator in Ophthalmic Treatments

Introduction

Gregory L McIntire is a notable inventor based in Florham Park, NJ (US). He has made significant contributions to the field of ophthalmology, particularly in the development of treatments for elevated intraocular pressure. With a total of 4 patents to his name, McIntire's work has the potential to impact the lives of many individuals suffering from neurological conditions.

Latest Patents

Among his latest patents is a polymorph of brimonidine pamoate. This polymorph exhibits unique characteristics that are crucial for its application in compositions, devices, or implants aimed at treating or controlling elevated intraocular pressure. Additionally, it plays a vital role in providing neuroprotection to components of neurological tissue, specifically to prevent the progressive degeneration of such components. The composition, device, or implant can be particularly beneficial for protecting cells and components of the optic nerve system.

Career Highlights

Gregory L McIntire is currently associated with Bausch + Lomb Incorporated, a company renowned for its commitment to eye health. His work at Bausch + Lomb has allowed him to focus on innovative solutions that address critical issues in ophthalmology.

Collaborations

McIntire has collaborated with talented individuals such as Hongna Wang and Stephen R Davio. These collaborations have further enriched his research and development efforts, leading to advancements in the field.

Conclusion

Gregory L McIntire's contributions to ophthalmic treatments through his innovative patents highlight his dedication to improving patient care. His work continues to pave the way for advancements in the treatment of elevated intraocular pressure and neuroprotection.